Cargando…
Radionuclide I-131 Labeled Albumin-Paclitaxel Nanoparticles for Synergistic Combined Chemo-radioisotope Therapy of Cancer
Development of biocompatible/biodegradable materials with multiple functionalities via simple methods for cancer combination therapy has attracted great attention in recent years. Herein, paclitaxel (PTX), a popular anti-tumor chemotherapeutic drug, is used to induce the self-assembly of human serum...
Autores principales: | Tian, Longlong, Chen, Qian, Yi, Xuan, Wang, Guanglin, Chen, Jie, Ning, Ping, Yang, Kai, Liu, Zhuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327637/ https://www.ncbi.nlm.nih.gov/pubmed/28255354 http://dx.doi.org/10.7150/thno.17381 |
Ejemplares similares
-
Radionuclide (131)I-labeled albumin-indocyanine green nanoparticles for synergistic combined radio-photothermal therapy of anaplastic thyroid cancer
por: Zhang, Xuemei, et al.
Publicado: (2022) -
(131)I-labeled polyethylenimine-entrapped gold nanoparticles for targeted tumor SPECT/CT imaging and radionuclide therapy
por: Sun, Na, et al.
Publicado: (2019) -
Silica Nanoparticles as Substrates for Chelator-free
Labeling of Oxophilic Radioisotopes
por: Shaffer, Travis M., et al.
Publicado: (2015) -
Hepatoma-Targeted Radionuclide Immune Albumin Nanospheres: (131)I-antiAFPMcAb-GCV-BSA-NPs
por: Lin, Mei, et al.
Publicado: (2016) -
Therapy of cervical cancer using (131)I-labeled nanoparticles
por: Li, Wei, et al.
Publicado: (2018)